Lazard Frères Gestion’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,773
Closed -$223K 80
2023
Q4
$223K Hold
7,773
0.01% 77
2023
Q3
$255K Buy
7,773
+200
+3% +$7.07K 0.01% 75
2023
Q2
$276K Sell
7,573
-250
-3% -$9.73K 0.01% 73
2023
Q1
$269K Buy
7,823
+1,573
+25% +$67.9K 0.01% 70
2022
Q4
$320K Sell
6,250
-1,702
-21% -$81.6K 0.01% 67
2022
Q3
$348K Hold
7,952
0.01% 67
2022
Q2
$414K Buy
7,952
+1,702
+27% +$86.7K 0.01% 58
2022
Q1
$323K Hold
6,250
0.01% 61
2021
Q4
$368K Hold
6,250
0.01% 60
2021
Q3
$268K Hold
6,250
0.01% 63
2021
Q2
$206K Buy
+6,250
New +$243K 0.01% 65

Other funds holding PFE

Lazard Frères Gestion's PFE Position: Q1 2024 in Review

Lazard Frères Gestion sold out of Pfizer (PFE) in Q1 2024, closing a stake of 7,773 shares — an estimated $223K sold.

Lazard Frères Gestion first reported a position in PFE in Q2 2021 and held it in 11 quarters. The position peaked at $414K in Q2 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Lazard Frères Gestion reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Lazard Frères Gestion sold 7,773 Pfizer shares in Q1 2024, an estimated $223K.
  • Lazard Frères Gestion first reported a position in Pfizer in Q2 2021 and held it in 11 quarters.
  • Lazard Frères Gestion's Pfizer position peaked at $414K in Q2 2022.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Lazard Frères Gestion's 13F filing for Q1 2024, filed 10 May 2024.